Aura Biosciences, Inc.

NASDAQ:AURA

5.47 (USD) • At close May 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -86.919-76.408-58.763-35.251-22.206-24.2
Depreciation & Amortization 1.2231.2951.1770.8310.8310.509
Deferred Income Tax 0000.01400.011
Stock Based Compensation 11.7228.7726.4122.3070.7360.507
Change In Working Capital -2.6424.441-3.102-0.315-3.6792.464
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.482-1.040.341.054-1.7211.043
Other Working Capital -3.1245.481-3.442-1.369-1.9581.421
Other Non Cash Items -3.189-1.947-0.3250.004-0.0030.043
Operating Cash Flow -79.805-63.847-54.601-32.41-24.321-20.666
Investing Activities:
Investments In Property Plant And Equipment -1.253-0.709-1.094-2.125-0.771-2.221
Acquisitions Net 000.067000
Purchases Of Investments -59.108-233.651-119.784000
Sales Maturities Of Investments 129.182120.39753.009000
Other Investing Activites 00-0.067000
Investing Cash Flow 68.821-113.963-67.869-2.125-0.771-2.221
Financing Activities:
Debt Repayment 00000-0.037
Common Stock Issued 03.178.54978.69710.0739.763
Common Stock Repurchased 00000-0.013
Dividends Paid 000000
Other Financing Activities 1.59594.1287.0887.56219.94339.763
Financing Cash Flow 1.59597.2995.629166.25910.03639.726
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -9.389-80.52-26.841131.724-15.05616.839
Cash At End Of Period 32.46141.85122.37149.21117.48732.543